A Retrospective Real-World Study of Pyrotinib in HER-2 Positive Advanced Breast Cancer
Zhi Yang, Wei-Da Fu, Hua-Yan Gu, Jia-Ling Ding, Gui-Long Guo Department of Breast Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, People’s Republic of ChinaCorrespondence: Gui-Long Guo, Email guoguilong@sina.comPurpose: To explore the efficacy a...
Saved in:
| Main Authors: | Yang Z, Fu WD, Gu HY, Ding JL, Guo GL |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-03-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/a-retrospective-real-world-study-of-pyrotinib-in-her-2-positive-advanc-peer-reviewed-fulltext-article-CMAR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancer
by: Yongxia Li, et al.
Published: (2025-04-01) -
The Synergistic Effects of Pyrotinib Combined With Adriamycin on HER2-Positive Breast Cancer
by: Chaokun Wang, et al.
Published: (2021-05-01) -
Corrigendum: The synergistic effects of pyrotinib combined with adriamycin on HER2-positive breast cancer
by: Chaokun Wang, et al.
Published: (2025-03-01) -
Disitamab vedotin combined with pyrotinib as salvage treatment in Her-2-amplified treatment refractory metastatic colorectal cancer: a case report
by: Jianxin Chen, et al.
Published: (2025-02-01) -
Comparative Analysis of Clinical Efficacy and Safety of Pyrotinib Plus Capecitabine versus Trastuzumab Emtansine (T-DM1) as Second-Line Treatment for HER2-Positive Advanced Breast Cancer: A Retrospective Study
by: Han H, et al.
Published: (2025-04-01)